| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
02-01-2010, 09:30 AM
|
#1 | |||
|
||||
|
Magnate
|
Interim positive data from Phase IIa clinical study of Synosia Therapeutics' SYN115 announced
http://neurotalk.psychcentral.com/thread113541.html
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| SYN115 Phase IIa; positive data | Parkinson's Disease Clinical Trials | |||
| MJFF Funds Continuing Analysis of Data from Phase 2 Trial of CERE-120 | Parkinson's Disease | |||
| May2009: Ceregene Presents Additional Clinical Data Phase 2 Trial of CERE-120 for PD | Parkinson's Disease | |||
| Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for | ALS News & Research | |||
| Phase III Data on Safinamide | Parkinson's Disease | |||
SYN115 Phase IIa; positive data
Linear Mode
